Patents expiring in 2029

US 7544364

Pharmaceutical compositions containing a glycopeptide antibiotic and a cyclodextrin

Theravance, Inc. · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544481

Nucleic acids encoding CD40 binding protein

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544486

Nell peptide expression systems and bone formation activity of nell peptide

The Regents of the University of California · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544670

HoxD3, HoxA3 and HoxB3 compositions and methods for improved wound healing

The Regents of the University of California · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7544778

Recombinant antigens for diagnosis and prevention of murine typhus

United States of America as represented by the Secretary of the Air Force · Granted Tue Jun 09 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 04 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547806

Tannate salt of rasagiline

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547773

Nucleic acid molecules encoding prostate specific antigen oligo epitope peptides

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547726

AI-2 compounds and analogs based on Salmonella typhimurium LsrB structure

THE TRUSTEES OF PRINCETON UNIVERSITY · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547759

Induction of tumor immunity by variants of folate binding protein

The Board of Regents of the University of Texas System · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547509

Cyanovirin variant-polymer conjugates

Nektar Therapeutics AL, Corporation · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547712

Methods for decreasing the toxic effects of nicotine on fetuses in pregnant women

United States of America as Represented by the Secretary, DHHS Office of Technology Transfer, National Institutes of Health · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547698

Bicyclic heterocyclic derivatives and their use as inhibitors of stearoyl-coadesaturase (SCD)

Xenon Pharmaceuticals Inc. · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547787

Processes for preparing montelukast sodium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547546

Progenitor cells from wharton's jelly of human umbilical cord

Tissue Regeneration Therapeutics Inc. · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547716

Sulfonamide derivatives

Institute of Medicinal Molecular Design, Inc. · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547686

Combretastatin A-3 prodrug

ARIZONA BOARD OF REGENTS, A BODY CORPORATE OF THE STATE OF ARIZONA ACTING FOR AND ON BEHALF OF ARIZONA STATE UNIVERSITY · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547762

T24 antigen for immunodiagnosis of Taenia solium cysticercosis

The United States of America, as represented by the Department of Health and Human Services · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7547794

Compositions useful as inhibitors of protein kinases

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2009076388

CONJUGUÉS VECTEUR DE CIBLAGE - PHOSPHOLIPIDE

BRACCO INT BV [NL] · Granted Thu Jun 18 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 13 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550584

Methods of purifying beta glucans

Immudyne, Inc. · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550617

Compositions and methods for the treatment of renal and cardiovascular disease

The Board of Regents of the University of Texas System · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550587

Photosensitizer and method for production thereof

Obschestvo S Ogranichennoi Otvetstvennostiju “Rada-Pharma” · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550595

Biphenyl compounds useful as muscarinic receptor antagonists

Theravance, Inc. · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550503

Physiologically active substances

American Regent, Inc. · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550460

2,4-pyrimidinediamine compounds and their uses

Rigel Pharmaceuticals, Inc. · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550454

Amino substituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550275

Expression, purification and uses of a Plasmodium falciparum liver stage antigen 1 polypeptide

United States of America as represented by the Secretary of the Air Force · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550459

Tetrahydroquinoline analogues as muscarinic agonists

ACADIA Pharmaceuticals Inc. · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550141

Methods for imaging tumor vasculature using conjugates that bind to aminophospholipids

The Board of Regents of the University of Texas System · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550005

Coated implantable medical device

Cook Regentec LLC · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550598

Kinase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7550590

Dipeptidyl peptidase inhibitors

Takeda Pharmaceutical Company Limited · Granted Tue Jun 23 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 18 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553936

Anti-TREM-like transcript-1 (TLT-1) antibodies and compositions

UNITED STATES OF AMERICA, AS REPRESENTED BY SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553962

Cross-linked glycopeptide-cephalosporin antibiotics

Theravance, Inc. · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7554021

Composition and method for self-assembly and mineralization of peptide amphiphiles

Northwestern University · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553935

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553484

Modulating neuronal outgrowth via the major histocompatibility complex class I (MHC I) molecule

The Regents of the University of California · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553971

Aryl aniline β2 adrenergic receptor agonists

Theravance, Inc. · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553840

4-phenyl-6-(2,2,2-trifluoro-1-phenylethoxy)pyrimidine-based compounds and methods of their use

LEXICON PHARMACEUTICALS, INC. · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553931

Complement depletion using recombinant human C3-derivatives

PLS-Design GmbH · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553867

Furan or thiophene derivative and medicinal use thereof

Takeda Pharmaceutical Company Limited · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553855

Compositions of N-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553934

Modified vitamin K-dependent polypeptides

Regents of the University of Minnesota · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553653

Variants and chemically-modified variants of phenylalanine ammonia-lyase

BIOMARIN PHARMACEUTICAL INC. · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553490

Vaccines against Escherichia coli O157 infection

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 7553852

Caspase inhibitors and uses thereof

Vertex Pharmaceuticals Incorporated · Granted Tue Jun 30 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 25 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

AU 2008340179

Pharmaceutical composition for the parenteral administration of ultrashort-effective beta-adrenoreceptor antagonists

AOP ORPHAN PHARMACEUTICALS AG [AT] · Granted Thu Jul 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

US 2009171262

Method and Mixture for In Vivo Photochemical Cross-Linking of Collagen

GRAEFE SUSANNA [DE] · Granted Thu Jul 02 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Jun 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)